These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9012602)

  • 1. Re: "Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard".
    Andersen S
    Am J Epidemiol; 1997 Feb; 145(3):290-1. PubMed ID: 9012602
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening without a "gold standard": the Hui-Walter paradigm revisited.
    Johnson WO; Gastwirth JL; Pearson LM
    Am J Epidemiol; 2001 May; 153(9):921-4. PubMed ID: 11323324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bayesian approach to decompression sickness model parameter estimation.
    Howle LE; Weber PW; Nichols JM
    Comput Biol Med; 2017 Mar; 82():3-11. PubMed ID: 28119191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown.
    Enøe C; Georgiadis MP; Johnson WO
    Prev Vet Med; 2000 May; 45(1-2):61-81. PubMed ID: 10802334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian inference in two-phase prevalence studies.
    Erkanli A; Soyer R; Stangl D
    Stat Med; 1997 May; 16(10):1121-33. PubMed ID: 9179978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating disease prevalence in the absence of a gold standard.
    Black MA; Craig BA
    Stat Med; 2002 Sep; 21(18):2653-69. PubMed ID: 12228883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interpretation of test sensitivity in the two-test two-population problem: assumptions matter.
    Johnson WO; Gardner IA; Metoyer CN; Branscum AJ
    Prev Vet Med; 2009 Oct; 91(2-4):116-21. PubMed ID: 19651450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of indirect fluorescent antibody test (IFAT) for the diagnosis and screening of lumpy skin disease using Bayesian method.
    Gari G; Biteau-Coroller F; LeGoff C; Caufour P; Roger F
    Vet Microbiol; 2008 Jun; 129(3-4):269-80. PubMed ID: 18242888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard.
    Joseph L; Gyorkos TW; Coupal L
    Am J Epidemiol; 1995 Feb; 141(3):263-72. PubMed ID: 7840100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic tests without gold standards.
    Hui SL; Zhou XH
    Stat Methods Med Res; 1998 Dec; 7(4):354-70. PubMed ID: 9871952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian estimation for performance measures of two diagnostic tests in the presence of verification bias.
    Aragon DC; Martinez EZ; Achcar JA
    J Biopharm Stat; 2010 Jul; 20(4):821-34. PubMed ID: 20496208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian sample size for diagnostic test studies in the absence of a gold standard: Comparing identifiable with non-identifiable models.
    Dendukuri N; Bélisle P; Joseph L
    Stat Med; 2010 Nov; 29(26):2688-97. PubMed ID: 20803558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of diagnostic tests in the absence of a gold standard using an Anaplasma marginale field data set].
    Müllner P; Dreher UM; Meli ML; Lutz H; Hofman-Lehmann R; Doherr MG
    Berl Munch Tierarztl Wochenschr; 2005; 118(9-10):416-22. PubMed ID: 16206931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of prevalence on the basis of screening tests.
    Lew RA; Levy PS
    Stat Med; 1989 Oct; 8(10):1225-30. PubMed ID: 2814071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical epistemology of sensitivity and specificity.
    Diamond GA
    J Clin Epidemiol; 1992 Jan; 45(1):9-13; discussion 15-6. PubMed ID: 1738017
    [No Abstract]   [Full Text] [Related]  

  • 17. Bayes theorem: Fully informed rational estimates of diagnostic probabilities.
    J Am Dent Assoc; 2010 Jun; 141(6):658-9. PubMed ID: 20516096
    [No Abstract]   [Full Text] [Related]  

  • 18. A Bayesian approach to model the conditional correlation between several diagnostic tests and various replicated subjects measurements.
    Pereira da Silva HD; Ascaso C; Gonçalves AQ; Orlandi PP; Abellana R
    Stat Med; 2017 Sep; 36(20):3154-3170. PubMed ID: 28543307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian analysis of diagnostic test accuracy when disease state is unverified for some subjects.
    Pennello GA
    J Biopharm Stat; 2011 Sep; 21(5):954-70. PubMed ID: 21830925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Univariate and bivariate likelihood-based meta-analysis methods performed comparably when marginal sensitivity and specificity were the targets of inference.
    Dahabreh IJ; Trikalinos TA; Lau J; Schmid CH
    J Clin Epidemiol; 2017 Mar; 83():8-17. PubMed ID: 28063915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.